4//SEC Filing
Patel Chirag K. 4
Accession 0001209191-21-017008
CIK 0001723128other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:08 PM ET
Size
6.5 KB
Accession
0001209191-21-017008
Insider Transaction Report
Form 4
Patel Chirag K.
DirectorPresident & Co-CEO
Transactions
- Award
Performance-Based Restricted Stock Units
2021-03-01+926,640→ 926,640 total→ Class A Common Stock (926,640 underlying)
Footnotes (3)
- [F1]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Represents the maximum number of shares issuable under the performance-based restricted stock units.
- [F3]50% of the performance-based restricted stock units are earned and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $8 or higher for 60 consecutive calendar days during the three-year performance period. Additional performance-based restricted stock units are earned at higher levels and eligible to vest upon the Issuer's Class A Common Stock achieving an average closing price per share of $10 (75%), $12 (100%), $14 (125%), $16 (150%), $18 (175%) and $20 (200%), respectively, for 60 consecutive calendar days during the three-year performance period. For average 60-day closing stock prices between $12 and $20 per share, the number of performance-based restricted stock units that become earned will be determined using straight line interpolation. Any earned performance-based restricted stock units vest in full on February 29,2024, the last day of the performance period.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001738701
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:08 PM ET
- Size
- 6.5 KB